We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
A comprehensive guide to Spravato (esketamine) nasal spray for depression treatment, covering its uses, dosage, side effects, precautions, and FAQs for Indian readers.
Depression is a serious mood disorder that affects how you feel, think, and behave. While many effective treatments are available, some individuals struggle with treatment-resistant depression or experience severe symptoms, including suicidal thoughts. In such cases, new and innovative treatment options are crucial. Spravato, a prescription nasal spray containing the active ingredient esketamine, has emerged as a significant advancement in managing specific forms of depression in adults. This comprehensive guide aims to provide clear, practical information about Spravato for Indian readers, covering its uses, how it works, dosage, potential side effects, precautions, and when to seek medical help.
Spravato is a brand-name medication that contains esketamine, a derivative of ketamine. It is administered as a nasal spray and is approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) for specific indications in adults. Unlike traditional antidepressants that primarily target serotonin, norepinephrine, or dopamine, Spravato works differently. It is believed to target N-methyl-D-aspartate (NMDA) receptors in the brain. These receptors play a role in mood regulation, and blocking them is thought to help rapidly improve depressive symptoms in some individuals. The exact mechanism by which esketamine alleviates depression is still being researched, but its rapid action is a key characteristic.
Spravato is specifically approved for the treatment of the following conditions in adults, when used in conjunction with an oral antidepressant:
Spravato is administered under the supervision of a healthcare professional in a certified medical setting. It is crucial that patients do not self-administer Spravato at home. The treatment typically involves two phases:
During the initial 4 weeks, patients receive Spravato twice a week on separate days. The dosage is usually determined by the healthcare provider based on the individual's condition and response. Each dose consists of multiple sprays, with each nasal spray device delivering a specific amount of esketamine. For example, each device may release two sprays totaling 28 mg of esketamine.
If the healthcare provider determines that Spravato is effective, the patient may transition to the maintenance phase. In weeks 5 through 8, doses are typically administered once a week. From week 9 onwards, the frequency may be reduced further to once every 1 or 2 weeks, depending on the patient's ongoing response and the doctor's assessment.
Important Administration Notes:
A critical aspect of Spravato treatment is the mandatory monitoring period. After each dose, patients must be monitored by a healthcare professional for at least 2 hours. This monitoring includes assessing vital signs and evaluating for any adverse reactions. A healthcare professional will also assess the patient before they are cleared to leave the facility.
Like all medications, Spravato can cause side effects. Some are common, while others can be serious. It is vital for patients and their caregivers to be aware of these potential risks.
Spravato carries a boxed warning, which is the most serious type of warning issued by the FDA. This highlights potential risks that require careful attention:
It is imperative to contact your doctor immediately if you experience any severe or concerning side effects. If you believe you are having a medical emergency, call emergency services (like 108 or 112 in India) or go to the nearest emergency room immediately.
Spravato is not suitable for everyone. Certain conditions and situations make its use risky:
It is crucial to inform your doctor about all medications, supplements, and herbal products you are currently taking. Spravato can interact with other drugs, potentially increasing the risk of side effects or reducing its effectiveness. Stimulants and CNS depressants, in particular, may interact with Spravato.
If you suspect you have taken too much Spravato, seek immediate medical attention. Contact your doctor, a poison control center, or go to the nearest emergency room. Severe symptoms of overdose can be life-threatening.
Consult your doctor or a qualified healthcare professional if you:
Spravato offers a different approach compared to traditional oral antidepressants. Its rapid onset of action, particularly for suicidal ideation, can be life-saving. However, it is not a first-line treatment and requires administration in a supervised setting, which can be a logistical challenge for some. The decision to use Spravato is made on a case-by-case basis, weighing its potential benefits against its risks and considering the individual's specific circumstances and treatment history.
Managing depression is a journey that often requires a multifaceted approach. While medications like Spravato can be highly effective, they are most beneficial when combined with other forms of support, such as psychotherapy (talk therapy), lifestyle modifications, and a strong support system. If you or someone you know is struggling with depression, please reach out for help. Your mental well-being is paramount.
Spravato contains esketamine, which is a specific isomer of ketamine. While related, Spravato is a distinct pharmaceutical product approved for specific medical uses under strict protocols.
No. Due to the potential for sedation and cognitive impairment, you must arrange for a responsible adult to drive you home after your Spravato treatment. You should not drive, operate machinery, or engage in any hazardous activities until you are sure you are no longer affected by the medication.
The rapid antidepressant effects can begin within hours or days for some individuals. However, the full therapeutic benefit and duration of effect vary greatly from person to person and depend on the treatment phase and individual response.
If you miss a scheduled dose, contact your healthcare provider immediately. They will advise you on the best course of action, which may involve rescheduling the dose or adjusting your treatment plan.
Availability and regulatory approval for medications can vary by country. It is essential to consult with your healthcare provider in India to determine if Spravato is approved and accessible in your region and if it is a suitable treatment option for you.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Visit Hospital
Near You
Discover advanced paralysis treatment in Supaul. Learn about rehabilitation, therapies, and specialist care for improved recovery and quality of life.
May 19, 2026
Explore paralysis treatment options in Jehanabad. Learn about therapies, specialists, and recovery strategies for enhanced quality of life.
May 19, 2026
Explore paralysis treatment options in Jamalpur. Learn about therapies, rehabilitation, and expert care for recovery and improved quality of life.
May 19, 2026